---
document_datetime: 2023-09-21 17:12:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/adasuve-epar-all-authorised-presentations_en.pdf
document_name: adasuve-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9204616
conversion_datetime: 2025-12-20 11:51:01.582985
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form              | Route of administration   | Immediate Packaging                     | Pack size                  |
|------------------|-------------------|------------|----------------------------------|---------------------------|-----------------------------------------|----------------------------|
| EU/1/13/823/001  | ADASUVE           | 4.5 mg     | Inhalation powder, pre-dispensed | Inhalation use            | inhaler (polycarbonate/stainless steel) | 5 x 1 inhalers (unit dose) |
| EU/1/13/823/002  | ADASUVE           | 9.1 mg     | Inhalation powder, pre-dispensed | Inhalation use            | inhaler (polycarbonate/stainless steel) | 5 x 1 inhalers (unit dose) |
| EU/1/13/823/003  | ADASUVE           | 4.5 mg     | Inhalation powder, pre-dispensed | Inhalation use            | inhaler (polycarbonate/stainless steel) | 1 inhaler                  |
| EU/1/13/823/004  | ADASUVE           | 9.1 mg     | Inhalation powder, pre-dispensed | Inhalation use            | inhaler (polycarbonate/stainless steel) | 1 inhaler                  |